Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BARKA Therapeutics ApS
APS
Active
Advertising protection
CVR 44860627
Slotsmarken 11, 2970
Hørsholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 2 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BARKA Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
DKK thousands
Item
2024
Revenue
0
Staff expenses
-0
EBITDA
-51
Depreciation & amort.
-0
EBIT
-51
Net financials
-70
Profit before tax
-121
Tax
-7
Net profit
-114
Balance sheet
DKK thousands
Item
2024
Total assets
1.599
Equity
276
Long-term debt
1.270
Short-term debt
53
Total debt
1.324
Financial ratios
5-year trend
EBITDA margin
-5081800.0%
This company
15.8%
Market median
-32163391% vs market
2024
2024
Equity ratio
17.2%
This company
38.2%
Market median
-55% vs market
2024
2024
Return on equity
-41.5%
This company
18.4%
Market median
-326% vs market
2024
2024
Net profit margin
-11444400.0%
This company
8.1%
Market median
-141288989% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
4.80×
This company
0.62×
Market median
-674% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-05-29 – 2024-12-31
View
PDF
More on BARKA Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
